The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
Share
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
NIH Leader: AI Must Do the Right Thing, Not Just Do It Right
NIH's Joe Croghan discusses AI ethics, human oversight, risk management and how the Biogenesis initiative could accelerate biomedical research.
7m watch -
How Edge AI Is Shaping the Future of Federal Missions
HP's Leif Olson discussed how edge AI can help federal agencies strengthen security, control costs and improve mission efficiency.
9m watch -
AI Drives Cybersecurity Strategies Beyond Patching to Thwart Vulnerabilities
NinjaOne's Egon Rinderer discussed how AI-driven cyber threats are changing vulnerability management and why agencies need to move beyond patching.
20m watch -
How Zero Trust Can Help Agencies Secure Emerging AI Capabilities
Island's Monty Montgomery discussed how zero trust can help federal agencies secure AI systems and manage emerging risks.
6m watch